Find information on Irritable Bowel Syndrome with Diarrhea IBS-D diagnosis codes including ICD-10 K58.0 and related medical billing documentation. Learn about healthcare provider clinical evaluation, Rome IV criteria, symptom management, and treatment for IBS with diarrhea. This resource covers IBS-D differential diagnosis, common comorbidities, and coding guidelines for accurate medical records. Explore resources for healthcare professionals on managing patients with Irritable Bowel Syndrome Diarrhea predominant.
Also known as
Irritable bowel syndrome
Encompasses various forms of irritable bowel syndrome.
Functional intestinal disorders
Other functional intestinal disorders not classified elsewhere.
Other abdominal pain
May include abdominal pain associated with IBS symptoms.
When to use each related code
| Description |
|---|
| Irritable Bowel Syndrome with Diarrhea |
| Functional Diarrhea |
| Bile Acid Diarrhea |
Coding IBS-D as general IBS (K58.9) without documenting diarrhea subtype leads to inaccurate severity and treatment reflection.
Missing documentation and coding of common IBS-D comorbidities like anxiety, depression, or fibromyalgia impacts risk adjustment and care.
Coding diarrhea (R19.7) without a confirmed IBS-D diagnosis leads to underreporting of the chronic condition and impacts quality metrics.
Patient presents with complaints consistent with Irritable Bowel Syndrome with Diarrhea (IBS-D). Symptoms include chronic abdominal pain, cramping, bloating, and frequent loose or watery stools. The patient reports experiencing these symptoms for the past six months, with exacerbations related to stress and certain food triggers. The patient denies fever, weight loss, rectal bleeding, or nocturnal symptoms. Physical examination reveals a soft, non-tender abdomen with normal bowel sounds. No masses or organomegaly were noted. Diagnostic considerations include ruling out other conditions such as inflammatory bowel disease (IBD), celiac disease, and lactose intolerance. Initial laboratory workup will include a complete blood count (CBC), comprehensive metabolic panel (CMP), and stool studies to exclude infection and inflammation. Based on the Rome IV criteria for IBS-D and the absence of alarm symptoms, a diagnosis of IBS-D is suspected. Patient education regarding dietary modifications, including a low FODMAP diet, stress management techniques, and the role of the gut-brain axis in IBS symptom management, was provided. Pharmacological interventions, including antidiarrheal medications such as loperamide and antispasmodics, will be considered if lifestyle modifications are insufficient. Follow-up appointment scheduled in four weeks to assess symptom response to initial interventions. ICD-10 code K58.0 will be used for billing purposes. Differential diagnoses include IBD, microscopic colitis, bile acid malabsorption, and small intestinal bacterial overgrowth (SIBO). The patient was advised to return sooner if symptoms worsen or new symptoms develop.